SEMrush Holdings Files Preliminary Proxy Solicitation Materials
Ticker: SEMR · Form: DEFA14A · Filed: Nov 20, 2025 · CIK: 1831840
| Field | Detail |
|---|---|
| Company | Semrush Holdings, Inc. (SEMR) |
| Form Type | DEFA14A |
| Filed Date | Nov 20, 2025 |
| Risk Level | low |
| Pages | 5 |
| Reading Time | 6 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, sec-filing
Related Tickers: SEMR
TL;DR
SEMrush just dropped preliminary proxy docs, get ready for shareholder votes.
AI Summary
SEMrush Holdings, Inc. (the "Company") has filed a DEFA14A, indicating it is soliciting materials prior to furnishing a definitive proxy statement. This filing is related to preliminary communications with security holders and does not require a filing fee.
Why It Matters
This filing signals that SEMrush is preparing for a shareholder meeting or vote, which could involve important corporate decisions or proposals that may impact investors.
Risk Assessment
Risk Level: low — This is a routine procedural filing related to proxy statements, not an announcement of significant financial or operational changes.
Key Players & Entities
- SEMrush Holdings, Inc. (company) — Registrant
- 0000950103-25-015106 (filing_id) — Accession Number
FAQ
What is the purpose of this DEFA14A filing?
This DEFA14A filing relates solely to preliminary communications made prior to furnishing security holders of SEMrush Holdings, Inc. with a definitive proxy statement.
Is a filing fee required for this document?
No fee is required for this filing, as indicated by the 'No fee required' checkbox being selected.
What is the filing date of this document?
The filing date is 20251120.
What is the company's Central Index Key (CIK)?
The company's Central Index Key is 0001831840.
What is the company's fiscal year end?
The company's fiscal year end is 1231.
Filing Stats: 1,507 words · 6 min read · ~5 pages · Grade level 17.9 · Accepted 2025-11-20 16:58:46
Filing Documents
- dp237739_defa14a.htm (DEFA14A) — 20KB
- image_001.gif (GRAPHIC) — 35KB
- 0000950103-25-015106.txt ( ) — 69KB
Forward-looking statements by their nature address
Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements regarding the transactions contemplated by the Merger Agreement (the “ Transaction ”), including the expected time period to consummate the Transaction, opportunities, anticipated future performance, expected share buyback programs and expected dividends. All such forward-looking statements are based upon current plans, estimates, expectations and ambitions that are subject to risks, uncertainties and assumptions, many of which are beyond the control of the Company, that could cause actual results to differ materially from those expressed in such forward-looking statements. Key factors that could cause actual results to differ materially include, but are not limited to, the expected timing and likelihood of completion of the Transaction, including the timing, receipt and terms and conditions of any required governmental and regulatory approvals of the Transaction; the occurrence of any event, change or other circumstances that could give rise to the termination of the Merger Agreement; the possibility that the Company’s stockholders may not approve the Transaction; the risk that the parties may not be able to satisfy the conditions to the Transaction in a timely manner or at all; risks related to disruption of management time from ongoing business operations due to the Transaction; the risk that any announcements relating to the Transaction could have adverse effects on the market price of the Company’s common stock; the risk that the Transaction and its announcement could have an adverse effect on the parties’ business relationships and business generally, including the ability of the Company to retain customers and retain and hire key personnel and maintain relationships with their suppliers and customers, and on their operating results and businesses generally; the risk of unforeseen or unknown liabilities; custome